Hijacking of RIG-I signaling proteins into virus-induced cytoplasmic structures correlates with the inhibition of type I interferon responses.

PubWeight™: 1.10‹?› | Rank: Top 10%

🔗 View Article (PMC 3993744)

Published in J Virol on January 29, 2014

Authors

Felix W Santiago1, Lina M Covaleda, Maria T Sanchez-Aparicio, Jesus A Silvas, Ana C Diaz-Vizarreta, Jenish R Patel, Vsevolod Popov, Xue-jie Yu, Adolfo García-Sastre, Patricia V Aguilar

Author Affiliations

1: Department of Pathology, University of Texas Medical Branch, Galveston, Texas, USA.

Articles citing this

Rabies Virus Infection Induces the Formation of Stress Granules Closely Connected to the Viral Factories. PLoS Pathog (2016) 1.40

RIG-I-like receptor regulation in virus infection and immunity. Curr Opin Virol (2015) 1.07

Viral evasion of intracellular DNA and RNA sensing. Nat Rev Microbiol (2016) 0.98

Disruption of type I interferon signaling by the nonstructural protein of severe fever with thrombocytopenia syndrome virus via the hijacking of STAT2 and STAT1 into inclusion bodies. J Virol (2015) 0.94

Phleboviruses and the Type I Interferon Response. Viruses (2016) 0.90

Reverse genetics system for severe fever with thrombocytopenia syndrome virus. J Virol (2014) 0.89

Generation of mutant Uukuniemi viruses lacking the nonstructural protein NSs by reverse genetics indicates that NSs is a weak interferon antagonist. J Virol (2015) 0.85

Modeling severe fever with thrombocytopenia syndrome virus infection in golden Syrian hamsters: Importance of STAT2 in preventing disease and effective treatment with favipiravir. J Virol (2016) 0.78

Correlation of cytokine level with the severity of severe fever with thrombocytopenia syndrome. Virol J (2017) 0.78

Mechanisms of innate immune evasion in re-emerging RNA viruses. Curr Opin Virol (2015) 0.78

Host Responses and Regulation by NFκB Signaling in the Liver and Liver Epithelial Cells Infected with A Novel Tick-borne Bunyavirus. Sci Rep (2015) 0.78

Extracellular Vesicles Mediate Receptor-Independent Transmission of Novel Tick-Borne Bunyavirus. J Virol (2015) 0.78

Rift Valley fever virus NSs protein functions and the similarity to other bunyavirus NSs proteins. Virol J (2016) 0.78

Molecular Evolution and Spatial Transmission of Severe Fever with Thrombocytopenia Syndrome Virus Based on Complete Genome Sequences. PLoS One (2016) 0.77

Viral RNA Silencing Suppression: The Enigma of Bunyavirus NSs Proteins. Viruses (2016) 0.76

Ubiquitin-like modifier FAT10 attenuates RIG-I mediated antiviral signaling by segregating activated RIG-I from its signaling platform. Sci Rep (2016) 0.75

Host and Viral Modulation of RIG-I-Mediated Antiviral Immunity. Front Immunol (2017) 0.75

Synaptogyrin-2 Promotes Replication of a Novel Tick-borne Bunyavirus through Interacting with Viral Nonstructural Protein NSs. J Biol Chem (2016) 0.75

Pediatric huaiyangshan virus infection: A case report with literature review. IDCases (2017) 0.75

Mapping of transcription termination within the S segment of SFTS phlebovirus facilitated the generation of NSs-deletant viruses. J Virol (2017) 0.75

The TRIMendous Role of TRIMs in Virus-Host Interactions. Vaccines (Basel) (2017) 0.75

Differential Antagonism of Human Innate Immune Responses by Tick-Borne Phlebovirus Nonstructural Proteins. mSphere (2017) 0.75

A role for glycolipid biosynthesis in severe fever with thrombocytopenia syndrome virus entry. PLoS Pathog (2017) 0.75

Heartland virus NSs protein disrupts host defenses by blocking the TBK1 kinase-IRF3 transcription factor interaction and signaling required for interferon induction. J Biol Chem (2017) 0.75

Articles cited by this

Pathogen recognition and innate immunity. Cell (2006) 44.14

LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J (2000) 41.48

Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature (2006) 22.65

Pattern recognition receptors and inflammation. Cell (2010) 21.05

Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J Cell Biol (2005) 18.60

RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science (2006) 16.00

5'-Triphosphate RNA is the ligand for RIG-I. Science (2006) 15.78

Fever with thrombocytopenia associated with a novel bunyavirus in China. N Engl J Med (2011) 13.18

Innate immune recognition of viral infection. Nat Immunol (2006) 9.59

Cell type-specific involvement of RIG-I in antiviral response. Immunity (2005) 9.37

TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature (2007) 8.87

Intracellular pattern recognition receptors in the host response. Nature (2006) 8.04

Innate immunity to virus infection. Immunol Rev (2009) 7.04

Discovery of Atg5/Atg7-independent alternative macroautophagy. Nature (2009) 6.74

Type 1 interferons and the virus-host relationship: a lesson in détente . Science (2006) 6.33

Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell (2010) 5.83

The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc Natl Acad Sci U S A (2000) 5.46

Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe (2009) 5.12

The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J Virol (2003) 4.73

The interferon response circuit: induction and suppression by pathogenic viruses. Virology (2006) 4.56

RNA recognition and signal transduction by RIG-I-like receptors. Immunol Rev (2009) 4.41

Modification of intracellular membrane structures for virus replication. Nat Rev Microbiol (2008) 4.04

Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling. J Virol (2006) 3.84

Visualization of molecular interactions by fluorescence complementation. Nat Rev Mol Cell Biol (2006) 3.79

Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1. Mol Cell Biol (1998) 3.70

RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell (2010) 3.59

TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus. Cell (2004) 3.39

The Rab GTPase family. Genome Biol (2001) 3.37

Structural mechanism of RNA recognition by the RIG-I-like receptors. Immunity (2008) 2.81

Bunyamwera bunyavirus nonstructural protein NSs is a nonessential gene product that contributes to viral pathogenesis. Proc Natl Acad Sci U S A (2001) 2.63

RIG-I-like receptors: cytoplasmic sensors for non-self RNA. Immunol Rev (2011) 2.48

Identification of distinct signaling pathways leading to the phosphorylation of interferon regulatory factor 3. J Biol Chem (2001) 2.47

Processing of genome 5' termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PLoS One (2008) 2.45

NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase. J Virol (2009) 2.39

Hemorrhagic fever caused by a novel Bunyavirus in China: pathogenesis and correlates of fatal outcome. Clin Infect Dis (2011) 2.34

Roles of RIG-I N-terminal tandem CARD and splice variant in TRIM25-mediated antiviral signal transduction. Proc Natl Acad Sci U S A (2008) 2.19

Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation. PLoS Pathog (2009) 2.17

Hemorrhagic fever caused by a novel tick-borne Bunyavirus in Huaiyangshan, China. Zhonghua Liu Xing Bing Xue Za Zhi (2011) 2.15

A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells. PLoS Pathog (2008) 2.12

Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1. J Virol (2009) 2.10

Incoming RNA virus nucleocapsids containing a 5'-triphosphorylated genome activate RIG-I and antiviral signaling. Cell Host Microbe (2013) 1.95

RIG-I family RNA helicases: cytoplasmic sensor for antiviral innate immunity. Cytokine Growth Factor Rev (2007) 1.94

La Crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts. J Virol (2007) 1.90

Rab5 is necessary for the biogenesis of the endolysosomal system in vivo. Nature (2012) 1.82

Pathogenesis of emerging severe fever with thrombocytopenia syndrome virus in C57/BL6 mouse model. Proc Natl Acad Sci U S A (2012) 1.71

MDA5 participates in the detection of paramyxovirus infection and is essential for the early activation of dendritic cells in response to Sendai Virus defective interfering particles. J Immunol (2008) 1.68

Activation of innate defense against a paramyxovirus is mediated by RIG-I and TLR7 and TLR8 in a cell-type-specific manner. J Virol (2005) 1.66

Participation of rab5, an early endosome protein, in hepatitis C virus RNA replication machinery. J Virol (2007) 1.58

ATPase-driven oligomerization of RIG-I on RNA allows optimal activation of type-I interferon. EMBO Rep (2013) 1.54

NSs protein of rift valley fever virus promotes posttranslational downregulation of the TFIIH subunit p62. J Virol (2011) 1.41

Entry of bunyaviruses into mammalian cells. Cell Host Microbe (2010) 1.40

Capsid protein of eastern equine encephalitis virus inhibits host cell gene expression. J Virol (2007) 1.35

Localization of Bunyamwera bunyavirus G1 glycoprotein to the Golgi requires association with G2 but not with NSm. J Gen Virol (1994) 1.35

RabGEFs are a major determinant for specific Rab membrane targeting. J Cell Biol (2013) 1.26

Dual functions of Rift Valley fever virus NSs protein: inhibition of host mRNA transcription and post-transcriptional downregulation of protein kinase PKR. Ann N Y Acad Sci (2009) 1.24

Biogenesis of the sorting endosome: the role of Rab5. Traffic (2000) 1.22

MDA5 detects the double-stranded RNA replicative form in picornavirus-infected cells. Cell Rep (2012) 1.22

Induction of type I interferon by RNA viruses: cellular receptors and their substrates. Amino Acids (2009) 1.22

Use of fluorescence-activated vesicle sorting for isolation of Naked2-associated, basolaterally targeted exocytic vesicles for proteomics analysis. Mol Cell Proteomics (2008) 1.18

Suppression of the interferon and NF-κB responses by severe fever with thrombocytopenia syndrome virus. J Virol (2012) 1.17

A distinct role of Riplet-mediated K63-Linked polyubiquitination of the RIG-I repressor domain in human antiviral innate immune responses. PLoS Pathog (2013) 1.16

Arenavirus nucleoprotein targets interferon regulatory factor-activating kinase IKKε. J Virol (2012) 1.15

Expression of the Bunyamwera virus M genome segment and intracellular localization of NSm. Virology (1993) 1.14

Viral mediated redirection of NEMO/IKKγ to autophagosomes curtails the inflammatory cascade. PLoS Pathog (2012) 1.11

Modulation of YY1 activity by SAP30. Biochem Biophys Res Commun (2003) 0.99

Characterization of Rift Valley fever virus MP-12 strain encoding NSs of Punta Toro virus or sandfly fever Sicilian virus. PLoS Negl Trop Dis (2013) 0.98

Bunyaviruses and the type I interferon system. Viruses (2009) 0.96

Cell entry of avian reovirus follows a caveolin-1-mediated and dynamin-2-dependent endocytic pathway that requires activation of p38 mitogen-activated protein kinase (MAPK) and Src signaling pathways as well as microtubules and small GTPase Rab5 protein. J Biol Chem (2011) 0.96

Autophagy-independent LC3 function in vesicular traffic. Autophagy (2010) 0.93

Crimean-Congo hemorrhagic fever virus utilizes a clathrin- and early endosome-dependent entry pathway. Virology (2013) 0.90

Autophagy takes an alternative pathway. Autophagy (2010) 0.86

Unconventional use of LC3 by coronaviruses through the alleged subversion of the ERAD tuning pathway. Viruses (2011) 0.85

Bovine ephemeral fever virus uses a clathrin-mediated and dynamin 2-dependent endocytosis pathway that requires Rab5 and Rab7 as well as microtubules. J Virol (2012) 0.81

Inhibition of La Crosse virus replication by monensin, monovalent ionophore. J Gen Virol (1982) 0.80

Articles by these authors

Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science (2005) 17.19

A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science (2007) 8.38

Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol (2007) 7.18

Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature (2006) 6.46

Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity (2013) 5.47

Human host factors required for influenza virus replication. Nature (2010) 5.28

Programming the magnitude and persistence of antibody responses with innate immunity. Nature (2011) 5.18

Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe (2009) 5.12

Inhibition of interferon signaling by dengue virus. Proc Natl Acad Sci U S A (2003) 5.05

Nosocomial transmission of human granulocytic anaplasmosis in China. JAMA (2008) 5.01

Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J Virol (2006) 4.88

H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog (2008) 4.79

The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J Virol (2003) 4.73

Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J Virol (2005) 4.72

A single amino acid substitution in 1918 influenza virus hemagglutinin changes receptor binding specificity. J Virol (2005) 4.71

The guinea pig as a transmission model for human influenza viruses. Proc Natl Acad Sci U S A (2006) 4.58

Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins. J Virol (2003) 4.45

Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J Virol (2005) 4.31

Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza. Proc Natl Acad Sci U S A (2002) 4.26

Attenuation of equine influenza viruses through truncations of the NS1 protein. J Virol (2005) 4.16

Influenza virus vaccine based on the conserved hemagglutinin stalk domain. MBio (2010) 4.15

Ovarian tumor domain-containing viral proteases evade ubiquitin- and ISG15-dependent innate immune responses. Cell Host Microbe (2007) 4.14

Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc Natl Acad Sci U S A (2009) 4.12

Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus. Proc Natl Acad Sci U S A (2004) 4.00

IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc Natl Acad Sci U S A (2007) 3.98

Human HA and polymerase subunit PB2 proteins confer transmission of an avian influenza virus through the air. Proc Natl Acad Sci U S A (2009) 3.91

Interferon antagonist proteins of influenza and vaccinia viruses are suppressors of RNA silencing. Proc Natl Acad Sci U S A (2004) 3.85

Matrix protein 2 of influenza A virus blocks autophagosome fusion with lysosomes. Cell Host Microbe (2009) 3.79

Gain-of-function experiments on H7N9. Science (2013) 3.67

Multiple anti-interferon actions of the influenza A virus NS1 protein. J Virol (2007) 3.53

Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature (2008) 3.47

Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathog (2005) 3.44

A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of beta interferon and is attenuated in mice. J Virol (2003) 3.44

Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes. Proc Natl Acad Sci U S A (2010) 3.24

Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus. Proc Natl Acad Sci U S A (2010) 3.17

Multiple functions of the IKK-related kinase IKKepsilon in interferon-mediated antiviral immunity. Science (2007) 3.16

Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines. PLoS Pathog (2010) 3.08

Influenza research database: an integrated bioinformatics resource for influenza research and surveillance. Influenza Other Respir Viruses (2012) 3.04

Influenza A viruses: new research developments. Nat Rev Microbiol (2011) 3.00

Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses. Proc Natl Acad Sci U S A (2012) 2.96

Influenza virus evades innate and adaptive immunity via the NS1 protein. J Virol (2006) 2.94

Rickettsia species infecting Amblyomma cooperi ticks from an area in the state of São Paulo, Brazil, where Brazilian spotted fever is endemic. J Clin Microbiol (2004) 2.91

Mutations in the NS1 protein of swine influenza virus impair anti-interferon activity and confer attenuation in pigs. J Virol (2005) 2.88

Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing. Proc Natl Acad Sci U S A (2010) 2.81

Severe fever with thrombocytopenia syndrome virus, Shandong Province, China. Emerg Infect Dis (2012) 2.77

Single gene reassortants identify a critical role for PB1, HA, and NA in the high virulence of the 1918 pandemic influenza virus. Proc Natl Acad Sci U S A (2008) 2.72

Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza. J Virol (2008) 2.71

Global host immune response: pathogenesis and transcriptional profiling of type A influenza viruses expressing the hemagglutinin and neuraminidase genes from the 1918 pandemic virus. J Virol (2004) 2.67

Newcastle disease virus V protein is a determinant of host range restriction. J Virol (2003) 2.61

Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. J Virol (2006) 2.61

NS5 of dengue virus mediates STAT2 binding and degradation. J Virol (2009) 2.42

Replication fitness determines high virulence of influenza A virus in mice carrying functional Mx1 resistance gene. Proc Natl Acad Sci U S A (2007) 2.33

Avian flu: Gain-of-function experiments on H7N9. Nature (2013) 2.32

Pause on avian flu transmission research. Science (2012) 2.24

Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease. Proc Natl Acad Sci U S A (2006) 2.23

Existing antivirals are effective against influenza viruses with genes from the 1918 pandemic virus. Proc Natl Acad Sci U S A (2002) 2.21

Identification of cellular interaction partners of the influenza virus ribonucleoprotein complex and polymerase complex using proteomic-based approaches. J Proteome Res (2007) 2.21

Suppression of the antiviral response by an influenza histone mimic. Nature (2012) 2.18

Virulence-associated substitution D222G in the hemagglutinin of 2009 pandemic influenza A(H1N1) virus affects receptor binding. J Virol (2010) 2.17

Viral tricks to grid-lock the type I interferon system. Curr Opin Microbiol (2010) 2.17

The influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase and AP-1 transcription factors. J Virol (2002) 2.14

Transmission of influenza virus via aerosols and fomites in the guinea pig model. J Infect Dis (2009) 2.12

Type I interferon induction pathway, but not released interferon, participates in the maturation of dendritic cells induced by negative-strand RNA viruses. J Infect Dis (2003) 2.05

PB1-F2 expression by the 2009 pandemic H1N1 influenza virus has minimal impact on virulence in animal models. J Virol (2010) 2.01

Nipah virus V and W proteins have a common STAT1-binding domain yet inhibit STAT1 activation from the cytoplasmic and nuclear compartments, respectively. J Virol (2004) 1.98

Inhibition of Beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3. J Virol (2005) 1.96

Incoming RNA virus nucleocapsids containing a 5'-triphosphorylated genome activate RIG-I and antiviral signaling. Cell Host Microbe (2013) 1.95

Differential inhibition of type I interferon induction by arenavirus nucleoproteins. J Virol (2007) 1.95

The NS5 protein of the virulent West Nile virus NY99 strain is a potent antagonist of type I interferon-mediated JAK-STAT signaling. J Virol (2010) 1.94

The Mx1 gene protects mice against the pandemic 1918 and highly lethal human H5N1 influenza viruses. J Virol (2007) 1.93

Reverse genetics studies on the filamentous morphology of influenza A virus. J Gen Virol (2003) 1.92

Bartonella tamiae sp. nov., a newly recognized pathogen isolated from three human patients from Thailand. J Clin Microbiol (2007) 1.92

Transmission of pandemic H1N1 influenza virus and impact of prior exposure to seasonal strains or interferon treatment. J Virol (2010) 1.92

Virulence determinants of pandemic influenza viruses. J Clin Invest (2011) 1.87

Complete-proteome mapping of human influenza A adaptive mutations: implications for human transmissibility of zoonotic strains. PLoS One (2010) 1.87

Protective immunity to lethal challenge of the 1918 pandemic influenza virus by vaccination. Proc Natl Acad Sci U S A (2006) 1.83

Directed mutagenesis of the Rickettsia prowazekii pld gene encoding phospholipase D. Infect Immun (2009) 1.83

The M segment of the 2009 new pandemic H1N1 influenza virus is critical for its high transmission efficiency in the guinea pig model. J Virol (2011) 1.82

Functional replacement of the carboxy-terminal two-thirds of the influenza A virus NS1 protein with short heterologous dimerization domains. J Virol (2002) 1.81

Inefficient control of host gene expression by the 2009 pandemic H1N1 influenza A virus NS1 protein. J Virol (2010) 1.81

DENV inhibits type I IFN production in infected cells by cleaving human STING. PLoS Pathog (2012) 1.80

Influenza A virus-generated small RNAs regulate the switch from transcription to replication. Proc Natl Acad Sci U S A (2010) 1.77

Integration of clinical data, pathology, and cDNA microarrays in influenza virus-infected pigtailed macaques (Macaca nemestrina). J Virol (2004) 1.77

Rickettsia bellii and Rickettsia amblyommii in Amblyomma ticks from the State of Rondônia, Western Amazon, Brazil. J Med Entomol (2004) 1.77

Influenza vaccines: present and future. J Clin Invest (2002) 1.74

Mice lacking the ISG15 E1 enzyme UbE1L demonstrate increased susceptibility to both mouse-adapted and non-mouse-adapted influenza B virus infection. J Virol (2008) 1.73

Viruses and the type I interferon antiviral system: induction and evasion. Int Rev Immunol (2002) 1.73

Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector. J Virol (2006) 1.73

Oseltamivir-resistant variants of the 2009 pandemic H1N1 influenza A virus are not attenuated in the guinea pig and ferret transmission models. J Virol (2010) 1.72

Transcriptional role of p53 in interferon-mediated antiviral immunity. J Exp Med (2008) 1.72

Pause on avian flu transmission studies. Nature (2012) 1.71

The E3-ligase TRIM family of proteins regulates signaling pathways triggered by innate immune pattern-recognition receptors. Immunity (2013) 1.69

Negevirus: a proposed new taxon of insect-specific viruses with wide geographic distribution. J Virol (2012) 1.67

Dissection of the influenza A virus endocytic routes reveals macropinocytosis as an alternative entry pathway. PLoS Pathog (2011) 1.66

Influenza B virus NS1-truncated mutants: live-attenuated vaccine approach. J Virol (2008) 1.64

Effects of influenza A virus NS1 protein on protein expression: the NS1 protein enhances translation and is not required for shutoff of host protein synthesis. J Virol (2002) 1.63

Influenza A virus strains differ in sensitivity to the antiviral action of Mx-GTPase. J Virol (2008) 1.62

Identification of amino acid residues critical for the anti-interferon activity of the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. J Virol (2009) 1.61